Micotherapy Reishi

Micotherapy Reishi

Complemento alimenticio a base de Reishi (Ganoderma lucidum) de agricultura ecológica (IT BIO 006) - Made in Europe.

  


Propiedades:

También llamado "Hongo de la eterna juventud" y "Hongo de la inmortalidad", el Reishi es considerado tradicionalmente un útil remedio para restablecer el equilibrio del organismo, contribuyendo a mejorar la resistencia ante las enfermedades.


Finalidad para la salud:

El Reishi es un hongo en el que se han aislado numerosos compuestos bioactivos que explican en parte sus funciones. Los más relevantes son: polisacáridos, en especial betaglucanos, glicoproteínas, triterpenos, esteroles, aminoácidos, nucleósidos, vitaminas y minerales, entre ellos el germanio en elevada cantidad. Gracias a sus propiedades, el Reishi ayuda a regularizar y a reforzar el sistema inmunitario. Además, desarrolla una acción calmante natural, contribuyendo a mejorar la capacidad de manejar el estrés psicofísico.


Ingredientes:

·         Reishi (Ganoderma lucidum) de agricultura ecológica, hongo entero pulverizado y extracto seco (tit. 25% en polisacáridos)


Modo de empleo:

1 cápsula tres veces al día, preferentemente lejos de las comidas.


Envase:

envases de 30 y 90 cápsulas


Notas:

conservar en lugar fresco y seco.


Insertado en el registro de los complementos: código 62493


Código EAN: A923589004


CONTENIDO MEDIO DE LOS INGREDIENTES CARACTERIZADORES

POR DOSIS DIARIA (3 CAP)

Reishi extracto seco

Aporte de polisacáridos

960 mg

240 mg

Reishi micelio y cuerpo fructífero

240 mg


 
Bibliografía:

1. Zhou, Sh.; Gao, Y. The immunomodulating effects of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, reishi mushroom) (Aphyllo- phoromycetideae). Int. J. Med. Mushrooms 2002, 4 (1), 111.
2. Liu, G.T. Recent advances in research of pharmacology and clinical applications of Ganoderma P. Karst. species (Aphyllophoromycetideae) in China. Int. J. Med. Mushrooms 1999, 1 (1), 6368.
3. Ko, H-H., H. Chi-Feng, J-P. Wang & C-N. Lin, 2008. “Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae.” Phytochemistry Volume 69, Issue 1, January, Pages 234-239
4. TV Lasukova, AG Arbuzov, LN Maslov, and VN Burkova. Ganoderma lucidum extract in cardiac diastolic dysfunction and irreversible cardiomyocytic damage in ischemia and reperfusion of the isolated heart. Patol Fiziol Eksp Ter, Jan 2008; (1): 22-5.
5. Zhang HN, Lin ZB (2004). Hypoglycemic effects of Ganoderma lucidum polysacchrides.Acta Pharmacol. 25 (2):191-195
6. Tang W, Gao Y, Chen G, et al. A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia. J Med Food. 2005;8:53-58
7. R Zhang, S Xu, Y Cai, M Zhou, X Zuo and P Chan. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation. eCAM Advance Access published July 16, 2009
8. ZY Zhou, YP Tang, J Xiang, P Wua, HM Jin, Z Wang, M Mori, and DF Cai. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol, August 19, 2010; 131(1): 154-64
9. B Lakshmi, TA Ajith, N Jose, and KK Janardhanan Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol, September 19, 2006; 107(2): 297-303.
10. Y Shi, J Sun, H He, H Guo, and S Zhang. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. J Ethnopharmacol, May 22, 2008; 117(3): 415-9
11. YQ Li and SF Wang Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett, June 1, 2006; 28(11): 837-41.
12. Zhou, Sh.; Gao, Y.; Chen, G.; Dai, X.; Ye, J.;Gao, H. A phase I=II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int. J. Med. Mushrooms 2002, 4 (4), 321–328
13. Gao, Y.; Lan, J.; Dai, X.; Ye, J.; Zhou, Sh. A phase I/II study of Ling Zhi mushroom Ganoderma lucidum. (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int. J. Med. Mushrooms 2004, 6 (1).
14. Dott. Martin Powell. The Use of Ganoderma lucidum (Reishi) in the Management of Histamine-Mediated Allergic Responses. Nutrition Practitioner October 2004 (www.nutprac.com).
15. Sone Y, Okuda R, Wada N, Kishida E, Misaki A. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 1985;49:2641–53
16. Mao T, van De Water J, Keen CL, et al. Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int J Immunother 1999;15(1):13-22. 
17. Chan WK, Cheung CC, Law HK, et al. Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J Hematol Oncol. 2008;1(1):9
18. Gao Y, Zhou S, Jiang W, et al. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. Aug 2003;32(3):201-215
19. HY Hsu, KF Hua, WC Wu, J Hsu, ST Weng, TL Lin, CY Liu, RS Hseu, and CT Huang. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. J Cell Physiol, Apr 2008; 215(1): 15-26
20. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-_1 from prostate cancer cells. Biochem Biophys Res Commun 2005;330:46–52
21. Free radical scavenging and immunomodulatory activities of Ganoderma lucidum polysaccharides derivatives.J Wang, Y Wang, X Liu, Y Yuan, and T Yue . Carbohydr Polym, January 2, 2013; 91(1): 33-8


Para más información visite el sitio:  www.micotherapy.it

 

 

Ver también